Advertisement

Targeted pharmacotherapy for cardiovascular risk reduction in patients with diabetes undergoing liver transplantation

  • Anoop N. Koshy
    Correspondence
    Corresponding author at: FRACP, Cardiologist, Austin Hospital, 145 Studley Road, Heidelberg 3084, Victoria, Australia.
    Affiliations
    Department of Cardiology, Austin Health, Melbourne, Victoria, Australia

    The University of Melbourne, Parkville, Victoria, Australia
    Search for articles by this author
  • Omar Farouque
    Affiliations
    Department of Cardiology, Austin Health, Melbourne, Victoria, Australia

    The University of Melbourne, Parkville, Victoria, Australia
    Search for articles by this author
  • Paul J. Gow
    Affiliations
    The University of Melbourne, Parkville, Victoria, Australia

    Victorian Liver Transplant Unit, Austin Hospital, Melbourne, Victoria, Australia
    Search for articles by this author
      Dear Editor,
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Gitto S
        • De Maria N
        • Marzi L
        • Magistri P
        • Falcini M
        • Vitale G
        • Olivieri T
        • et al.
        Pre-transplant diabetes predicts atherosclerotic vascular events and cardiovascular mortality in liver transplant recipients: a long-term follow-up study.
        Eur J Intern Med. 2020;
        • Coss E
        • Watt KD
        • Pedersen R
        • Dierkhising R
        • Heimbach JK
        • Charlton MR
        Predictors of cardiovascular events after liver transplantation: a role for pretransplant serum troponin levels.
        Liver Transpl. 2011; 17: 23-31
        • Aravinthan AD
        • Fateen W
        • Doyle AC
        • Venkatachalapathy SV
        • Issachar A
        • Galvin Z
        • Sapisochin G
        • et al.
        The impact of preexisting and post-transplant diabetes mellitus on outcomes following liver transplantation.
        Transplantation. 2019; 103: 2523-2530
        • Koshy AN
        • Gow PJ
        • Han HC
        • Teh AW
        • Jones R
        • Testro A
        • Lim HS
        • et al.
        Cardiovascular mortality following liver transplantation: predictors and temporal trends over 30 years.
        Eur Heart J Qual Care Clin Outcomes. 2020;
        • Watt KD
        • Pedersen RA
        • Kremers WK
        • Heimbach JK
        • Charlton MR
        Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study.
        Am J Transplant. 2010; 10: 1420-1427
        • Koshy AN
        • Farouque O
        • Cailes B
        • Ko J
        • Han HC
        • Weinberg L
        • Testro A
        • et al.
        Prediction of perioperative cardiovascular events in liver transplantation.
        Transplantation. 2020; https://doi.org/10.1097/TP.0000000000003306
        • Konerman MA
        • Fritze D
        • Weinberg RL
        • Sonnenday CJ
        • Sharma P
        Incidence of and risk assessment for adverse cardiovascular outcomes after liver transplantation: a systematic review.
        Transplantation. 2017; 101: 1645-1657
        • Koshy AN GP
        • Han HC
        • Teh AW
        • Jones R
        • Lim HS
        • et al.
        Diabetes is an independent predictor of sudden cardiac death following liver transplantatoin: results from the Australian and New Zealand Liver Transplant Registry over 30 years.
        J Am Coll Cardiol. 2020; 75
        • Arnett DK
        • Blumenthal RS
        • Albert MA
        • Buroker AB
        • Goldberger ZD
        • Hahn EJ
        • Himmelfarb CD
        • et al.
        2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American college of cardiology/American heart association task force on clinical practice guidelines.
        J Am Coll Cardiol. 2019; 74: e177-e232
        • Patel SS
        • Rodriguez VA
        • Siddiqui MB
        • Faridnia M
        • Lin FP
        • Chandrakumaran A
        • Laurenzano J
        • et al.
        The impact of coronary artery disease and statins on survival after liver transplantation.
        Liver Transpl. 2019; 25: 1514-1523